Technical Analysis for RXRX - Recursion Pharmaceuticals, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 9.97 | -1.97% | -0.20 |
RXRX closed down 1.97 percent on Thursday, March 28, 2024, on 79 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.00% | |
NR7-2 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Multiple of Ten Bearish | Other | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
NR7 | Range Contraction | -1.97% | |
Narrow Range Bar | Range Contraction | -1.97% | |
Wide Bands | Range Expansion | -1.97% | |
Oversold Stochastic | Weakness | -1.97% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 14 hours ago |
Down 2 % | about 14 hours ago |
Possible NR7 | about 16 hours ago |
Fell Below Previous Day's Low | about 20 hours ago |
Down 1% | about 20 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/06/2024
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Monogenic Diseases Rare
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Monogenic Diseases Rare
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 16.745 |
52 Week Low | 4.54 |
Average Volume | 6,912,351 |
200-Day Moving Average | 9.32 |
50-Day Moving Average | 11.10 |
20-Day Moving Average | 11.00 |
10-Day Moving Average | 10.66 |
Average True Range | 0.92 |
RSI (14) | 40.83 |
ADX | 13.8 |
+DI | 22.26 |
-DI | 20.93 |
Chandelier Exit (Long, 3 ATRs) | 11.41 |
Chandelier Exit (Short, 3 ATRs) | 12.69 |
Upper Bollinger Bands | 12.39 |
Lower Bollinger Band | 9.60 |
Percent B (%b) | 0.13 |
BandWidth | 25.36 |
MACD Line | -0.38 |
MACD Signal Line | -0.23 |
MACD Histogram | -0.1489 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 10.48 | ||||
Resistance 3 (R3) | 10.53 | 10.40 | 10.40 | ||
Resistance 2 (R2) | 10.40 | 10.27 | 10.38 | 10.37 | |
Resistance 1 (R1) | 10.19 | 10.19 | 10.13 | 10.14 | 10.34 |
Pivot Point | 10.06 | 10.06 | 10.03 | 10.04 | 10.06 |
Support 1 (S1) | 9.85 | 9.93 | 9.79 | 9.80 | 9.60 |
Support 2 (S2) | 9.72 | 9.85 | 9.70 | 9.57 | |
Support 3 (S3) | 9.51 | 9.72 | 9.55 | ||
Support 4 (S4) | 9.46 |